$524.05 1.4%
TMO Stock Price vs. AI Score
Data gathered: December 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Thermo Fisher Scientific (TMO)

Analysis generated October 24, 2024. Powered by Chat GPT.

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories. The company operates through four segments: Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products and Services. With a mission to enable customers to make the world healthier, cleaner, and safer, Thermo Fisher Scientific has positioned itself as a critical player in the global scientific and healthcare landscape.

Read full AI stock Analysis

Stock Alerts - Thermo Fisher Scientific (TMO)

company logo Thermo Fisher Scientific | December 17
Over the past few months, there has been a noticeable downward trend in Job postings.
company logo Thermo Fisher Scientific | December 5
Insider Alert: CASPER MARC N is selling shares
company logo Thermo Fisher Scientific | November 12
Ro Khanna (member of U.S. congress) is buying shares
company logo Thermo Fisher Scientific | November 2
Over the past few months, there has been a noticeable downward trend in Job postings.

About Thermo Fisher Scientific

Thermo Fisher Scientific is an American supplier of scientific instrumentation, reagents and consumables, and software services.


Thermo Fisher Scientific
Price $524.05
Target Price Sign up
Volume 2,690,000
Market Cap $200B
Year Range $500.92 - $623.35
Dividend Yield 0.3%
PE Ratio 32.37
Analyst Rating 84% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2410.6B2.1B8.5B1.63B2.29B5.280
Q2 '2410.5B2.11B8.43B1.55B2.33B5.370
Q1 '249.98B2.76B7.22B1.33B2.52B5.110
Q4 '2310.4B2.81B7.62B1.63B2.72B5.670
Q3 '2310.2B2.09B8.13B1.72B2.71B5.690

Insider Transactions View All

CASPER MARC N filed to sell 101,192 shares at $534.7.
December 4 '24
CASPER MARC N filed to sell 110,392 shares at $529.5.
December 4 '24
CASPER MARC N filed to sell 101,197 shares at $534.
December 4 '24
CASPER MARC N filed to sell 109,047 shares at $530.9.
December 4 '24
CASPER MARC N filed to sell 105,695 shares at $532.
December 4 '24

What is the Market Cap of Thermo Fisher Scientific?

The Market Cap of Thermo Fisher Scientific is $200B.

What is Thermo Fisher Scientific's PE Ratio?

As of today, Thermo Fisher Scientific's PE (Price to Earnings) ratio is 32.37.

What is the current stock price of Thermo Fisher Scientific?

Currently, the price of one share of Thermo Fisher Scientific stock is $524.05.

How can I analyze the TMO stock price chart for investment decisions?

The TMO stock price chart above provides a comprehensive visual representation of Thermo Fisher Scientific's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Thermo Fisher Scientific shares. Our platform offers an up-to-date TMO stock price chart, along with technical data analysis and alternative data insights.

Does TMO offer dividends to its shareholders?

Yes, Thermo Fisher Scientific (TMO) offers dividends to its shareholders, with a dividend yield of 0.3%. This dividend yield represents Thermo Fisher Scientific's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Thermo Fisher Scientific in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Thermo Fisher Scientific?

Some of the similar stocks of Thermo Fisher Scientific are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.